IU scientists part of NIH-funded national consortium focused on improving Alzheimer’s disease diagnoses

Researchers at Indiana University School of Medicine will play key roles in a national consortium led by Wake Forest University School of Medicine to study the use, interpretation and implementation of biomarkers to diagnose Alzheimer’s disease. The multi-institution effort is funded by a five-year, $9 million grant from the National Institute on Aging, part of the National Institutes of Health, that will establish the Alzheimer’s Diagnosis in Older Adults with Chronic Conditions (ADACC) Network.

IU School of Medicine expands point-of-care ultrasound training

Indiana University School of Medicine is expanding its training program for point-of-care ultrasound (POCUS) by investing in portable ultrasound systems for all students, residents, and fellows across seven specialties to use in curricula and patient care at the academic health center in Indianapolis.

Internationally recognized computational researcher Spyridon Bakas, PhD, to serve as inaugural director of Division of Computational Pathology

Indiana University School of Medicine Department of Pathology is launching a new Division of Computational Pathology and a Research Center for Federated Learning in Precision Medicine.

Study: health equity an important aspect of improving quality of care provided to children in emergency departments

A new multi-site study led by Indiana University School of Medicine found increasing pediatric readiness in emergency departments reduces, but does not eliminate, racial and ethnic disparities in children and adolescents with acute medical emergencies.

Dr. Liana Apostolova is available to comment on new results of a phase III clinical trial of Donanemab, an Alzheimer’s disease medication for patients with early symptoms of the disease.

Liana Apostolova, MD is the associate dean of Alzheimer’s disease research at Indiana University School of Medicine. Dr. Apostolova and others presented results of the phase 3 clinical trial of Donanemab at the Alzheimer’s Association International Conference. The study, also published…

IU-developed statewide initiative shows primary care clinicians can diagnose autism in young children with high accuracy

A new study led by Indiana University School of Medicine researchers shows primary care clinicians who receive specialized training can make accurate autism diagnoses for over 80 percent of young children referred with developmental delays, providing compelling evidence that community-based models of autism evaluation are a potential solution for improving access to this needed service.